Now showing items 1-1 of 1
Bax expression remains unchanged following antisense treatment directed against BCL-2
(Humana Press, 2011-09)
Antisense oligonucleotides (oligos) have been evaluated in both in vivo and in vitro prostate cancer models. Although most contain a single mRNA binding site, our laboratory has also evaluated bispecific types directed ...